Radiotherapy & Oncology
Volume 90, Issue 1 , Pages 99-105 , January 2009

Helical tomotherapy for locoregional irradiation including the internal mammary chain in left-sided breast cancer: Dosimetric evaluation

  • Jean-Michel Caudrelier

      Affiliations

    • Department of Radiation Oncology, The Ottawa Hospital Cancer Centre, Ont., Canada
    • Corresponding Author InformationCorresponding author. Address: Department of Radiation Oncology, The Ottawa Hospital Cancer Centre, 501 Smyth Road, Ottawa, Ont., Canada.
  • ,
  • Scott C. Morgan

      Affiliations

    • Department of Radiation Oncology, The Ottawa Hospital Cancer Centre, Ont., Canada
  • ,
  • Lynn Montgomery

      Affiliations

    • Department of Radiation Oncology, The Ottawa Hospital Cancer Centre, Ont., Canada
  • ,
  • Manon Lacelle

      Affiliations

    • Department of Radiation Oncology, The Ottawa Hospital Cancer Centre, Ont., Canada
  • ,
  • Balazs Nyiri

      Affiliations

    • Department of Medical Physics, The Ottawa Hospital Cancer Centre, Ont., Canada
  • ,
  • Miller MacPherson

      Affiliations

    • Department of Medical Physics, The Ottawa Hospital Cancer Centre, Ont., Canada

Received 28 May 2008 ,Revised 28 August 2008 ,Accepted 7 September 2008.

References 

  1. Veronesi U, Cascinelli N, Bufalino R, et al. Risk of internal mammary lymph node metastases and its relevance on prognosis of breast cancer patients. Ann Surg. 1983;198:681–684
  2. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949–955
  3. Overgaard M, Jensen M, Overgaard J, et al. Postoperative radiotherapy in high-risk post-menopausal breast cancer patients given Tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641–1648
  4. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med. 1997;337:956–962
  5. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106
  6. Darby SC, McGale P, Taylor CW, Peto R. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer: prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol. 2005;6:557–565
  7. Patt DA, Goodwin JS, Kuo YF, et al. Cardiac morbidity of adjuvant radiotherapy for breast cancer. J Clin Oncol. 2005;23:7475–7482
  8. Taylor CW, Nisbet A, McGale P, Darby SC. Cardiac exposures in breast cancer radiotherapy: 1950s–1990s. Int J Radiat Oncol Biol Phys. 2007;69:1484–1495
  9. Taghian A, Jagsi R, Makris A, et al. Results of a survey regarding irradiation of internal mammary chain in patients with breast cancer: practice is culture driven rather than evidence based. Int J Radiat Oncol Biol Phys. 2004;60:706–714
  10. Klein EE, Taylor M, Michaletz-Lorenz M, Zoeller D, Umfleet W. A mono isocentric technique for breast and regional nodal therapy using dual asymmetric jaws. Int J Radiat Oncol Biol Phys. 1994;28:753–760
  11. Nyiri B, MacPherson M, Szanto J, et al. Forward-planned dose compensation for radiotherapy of the breast using MLC sub-fields. In: 21st Annual meeting of the European Society for Therapeutic Radiology and Oncology (ESTRO), Prague, Czech Republic (September 15–19, 2002); Radiother Oncol. 2002;64S1:S319 [Abstract].
  12. Cho BC, Hurkmans CW, Damen EM, Zijp LJ, Mijnheer BJ. Intensity modulated versus non-intensity modulated radiotherapy in the treatment of the left breast and upper internal mammary lymph node chain: a comparative planning study. Radiother Oncol. 2002;62:127–136
  13. Thilmann C, Sroka-Perez G, Krempien R, Hoess A, Wannenmacher M, Debus J. Inversely planned intensity modulated radiotherapy of the breast including the internal mammary chain: a plan comparison study. Technol Cancer Res Treatment. 2004;3:69–75
  14. Cozzi L, Fogliata A, Nicolini G, Bernier J. Clinical experience in breast irradiation with intensity modulated photon beams. Acta Oncol. 2005;44:467–474
  15. Fogliata A, Nicolini G, Alber M, et al. IMRT for breast a planning study. Radiother Oncol. 2005;76:300–310
  16. Krueger EA, Fraass BA, McShan DL, Marsh R, Pierce LJ. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2003;56:1023–1037
  17. Chui CS, Hong L, McCormick B. Intensity-modulated radiotherapy technique for three-field breast treatment. Int J Radiat Oncol Biol Phys. 2005;62:1217–1223
  18. Popescu CC, Olivotto I, Patenaude V, Wai E, Beckham WA. Inverse-planned, dynamic, multi-beam, intensity-modulated radiation therapy (IMRT): a promising technique when target volume is the left breast and internal mammary lymph nodes. Med Dosim. 2006;31:283–291
  19. Johansson J, Isacsson U, Lindman H, Montelius A, Glimelius B. Node-positive left-sided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques. Radiother Oncol. 2002;65:89–98
  20. Dijkema IM, Hofman P, Raaijmakers CP, Lagendijk JJ, Battermann JJ, Hillen B. Locoregional conformal radiotherapy of the breast: delineation of the regional lymph node clinical target volumes in treatment position. Radiother Oncol. 2004;71:287–295
  21. Montgomery L, Zohr R, Lacasse P, et al. Is it really useful to use a post axillary boost beam to treat axillary and infra/supraclavicular nodes in era of conformal radiotherapy? In: Annual meeting of the Canadian Association of Radiation Oncology (CARO), Halifax, Nova Scotia, Canada (September 9–12, 2004); Radiother Oncol. 2004;72S1: S15 [Abstract].
  22. Feuvret L, Noël G, Mazeron JJ, Bey P. Conformity index: a review. Int J Radiat Oncol Biol Phys. 2006;64:333–342
  23. Glantz SA. Primer of biostatistics. 6th ed.. Mc Graw-Hill Medical Publishing; 2005;
  24. Gagliardi G, Lax I, Ottolenghi A, Rutqvist LE. Long-term cardiac mortality after radiotherapy for breast cancer: application of the relative seriality model. Br J Radiol. 1996;69:839–846
  25. Mantini G, Smaniotto D, Balducci M, et al. Radiation-induced cardiovascular disease: impact of dose and volume. Rays. 2005;30:157–168
  26. Harris EE, Correa C, Hwang W-T, et al. Late cardiac mortality and morbidity in early stage breast cancer patients after breast conservation treatment. J Clin Oncol. 2006;24:4100–4106
  27. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003;56:83–88
  28. Kirova YM, Gambotti L, De Rycke Y, Vilcoq JR, Asselain B, Fourquet A. Risk of second malignancies after adjuvant radiotherapy for breast cancer: a large-scale, single-institution review. Int J Radiat Oncol Biol Phys. 2007;68:359–363
  29. Salminen EK, Pukkala E, Kiel KD, Hakulinen TT. Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer. Int J Radiat Oncol Biol Phys. 2006;65:699–704
  30. Roychoudhuri R, Evans H, Robinson D, Møller H. Radiation-induced malignancies following radiotherapy for breast cancer. Br J Cancer. 2004;91:868–872

PII: S0167-8140(08)00477-5

doi: 10.1016/j.radonc.2008.09.028

Radiotherapy & Oncology
Volume 90, Issue 1 , Pages 99-105 , January 2009